Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duclorexint: CHG Bathing for HAI Prevention in ICU
NCT03639363Phase 4Completed
- Sponsor
- University of Perugia
- Start
- Aug 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in Hospital-Acquired Infection (HAI) (2 arms), sponsored by University of Perugia. Primary endpoint: Hospital Acquired Infections Incidence. Started Aug 2015; status: completed.
02
Drugs
chlorhexidine
03
Conditions
Hospital-Acquired Infection (HAI)
Beyond the preview
Go deeper on NCT03639363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03639363.